Qu Biologics Inc.

Qu Biologics develops Site Specific Immunomodulators that aim to restore the body's innate immune system to treat cancer and immune-related diseases such as IBD

[Qu Biologics Inc. @QuBiologics]

We’ve completed enrolment in our RESILIENCE Study!
This Phase 2 trial explores how our novel SSI immunotherapy (QBKPN) could restore immune health in people 65+.
Big step towards our goal of reversing age-related immune decline!
Read more: https://t.co/xq0yJA6pxK

#Longevity

[Qu Biologics Inc. @QuBiologics]

Happy Canada Day!
Proud to be a Canadian biotech company working to transform immune health.
#CanadaDay #Biotech #ProudlyCanadian

[Qu Biologics Inc. @QuBiologics]

Interested in learning about the important role of natural immunity in health and aging? Join us this Friday at @sgseniors!

Date: February 21, Friday
Time: 1:00 PM - 2:00 PM
Location: South Granville Seniors Centre, 1420 W 12 Ave., Vancouver, BC
Tailored for people 65+

[Qu Biologics Inc. @QuBiologics]

Qu Biologics Inc. is pleased to report exciting data demonstrating that its QBECO immunomodulator clears senescence. The study was conducted in collaboration with @machealthsci.
Learn more: https://t.co/Q580o5h1dB

[Qu Biologics Inc. @QuBiologics]

Boost Your Immunity: Join Dr. Hal Gunn for a Presentation on Strengthening Your Immune System - Tailored for People 65+

Date: January 30, 2025
Time: 2:00 PM
Location: Rideau Retirement Residence
RSVP: Call/ Text Lianne @ 778-837-7031

[Qu Biologics Inc. @QuBiologics]

@McMasterU Learn more in our latest press release: https://t.co/b6XdnSNR6r

[Qu Biologics Inc. @QuBiologics]

@QuBiologics Inc. is pleased to report exciting data demonstrating that Qu Biologics’ QBECO SSI markedly improves fatty liver disease and its deleterious consequences in an animal model of preexisting obesity.

[Qu Biologics Inc. @QuBiologics]

The study was conducted in collaboration with Dr. Jon Schertzer who holds a Canada Research Chair in Metabolic Inflammation and is a Professor in the Department of Biochemistry and Biomedical Sciences at @McMasterU.

[Qu Biologics Inc. @QuBiologics]

@QuBiologics is pleased to report exciting survival data using a combination of Qu Biologics’ QBECO SSI and CAR T-cell therapy in an animal model of aggressive cancer conducted in collaboration with @NUSMedicine.

Learn more in our latest press release: https://t.co/sAnNWGUpbs

[Qu Biologics Inc. @QuBiologics]

Important Update: The October 23rd webinar on natural immunity and aging has been postponed. We’ll announce the new date soon, so please stay tuned.
Keep following us for updates on this informative presentation. Thank you for your patience and support!

[Ramona Kaptyn @captainramona]

Still time to register.
WEDNESDAY, OCTOBER 16, 2:30 p.m. at White Rock Community Centre on Russell Ave.
Call 604-228-2025 Ext. 41407

[Qu Biologics Inc. @QuBiologics]

If you would like to learn more about this Study, please contact the RESILIENCE Study team who will be pleased to discuss the Study and answer your questions.

Phone: [phone]
Email: [email protected]
Web: https://t.co/wFg5Sm8HVI

[Qu Biologics Inc. @QuBiologics]

Boost Your Immunity: Join Dr. Hal Gunn for a Webinar on Strengthening Your Immune System - Tailored for People 65+

Date: 23 October 2024
Time: 3:00 PM

[Qu Biologics Inc. @QuBiologics]

@QuBiologics is inviting Metro #Vancouver seniors to participate in a clinical trial assessing a new immunomodulator designed to restore immune function in the elderly.

To learn more, please read the full press release here:
https://t.co/PwbsQWWvFY

[Qu Biologics Inc. @QuBiologics]

@QuBiologics is pleased to announce a new #partnership with @FoundationATCG aimed at impacting the care of patients with late-stage colorectal #cancer.

Please read the full press release here:
https://t.co/HDOIiOti1s

[Qu Biologics Inc. @QuBiologics]

@QuBiologics is pleased to announce, in partnership with @TransBIOTech, being awarded a $450K Applied Research and Development #grant.

Please read the full press release here: https://t.co/sD5lB8ufop

[Qu Biologics Inc. @QuBiologics]

@QuBiologics is pleased to share that it has received Accelerating Clinical Trial (ACT) #Funding for its Phase 2 clinical study in late-stage colon cancer, PERIOP-06.

Please read the press release for more details:

https://t.co/PZyQY8cZyi

[Qu Biologics Inc. @QuBiologics]

See below: An exciting opportunity for a postdoctoral fellow to join Dr. Auer's research laboratory in the testing of QBECO, a first-in-class immunotherapy developed by @QuBiologics to improve post-operative outcomes for patients with liver metastases.

https://t.co/OgLqw8wH8O

[Qu Biologics Inc. @QuBiologics]

@QuBiologics is thrilled to announce an important new #collaboration with @karolinskainst to validate the molecular mechanisms of Qu's first-in-class #immunotherapy platform.

Please read the press release for more details: https://t.co/Tj2r53vgWX